Gene Page:RAB11FIP5
Summary?
| GeneID | 26056 |
| Symbol | RAB11FIP5 |
| Synonyms | GAF1|RIP11|pp75 |
| Description | RAB11 family interacting protein 5 (class I) |
| Reference | MIM:605536|HGNC:HGNC:24845|Ensembl:ENSG00000135631|HPRD:16117|Vega:OTTHUMG00000129779 |
| Gene type | protein-coding |
| Map location | 2p13 |
| Pascal p-value | 1.115E-5 |
| Sherlock p-value | 0.97 |
| eGene | Myers' cis & trans |
| 支持 | G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-FULL G2Cdb.human_BAYES-COLLINS-MOUSE-PSD-CONSENSUS |
Gene in Data Sources
| Gene set name | Method of gene set | Description | Info |
|---|---|---|---|
| CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
eQTL annotation
eQTL annotation| SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
|---|---|---|---|---|---|---|---|---|
| rs6720094 | chr2 | 73588075 | RAB11FIP5 | 26056 | 0.03 | cis | ||
| rs7574291 | chr2 | 73594940 | RAB11FIP5 | 26056 | 0.12 | cis | ||
| rs7598396 | chr2 | 73652627 | RAB11FIP5 | 26056 | 0.05 | cis | ||
| rs1083922 | chr2 | 73704002 | RAB11FIP5 | 26056 | 0.07 | cis | ||
| rs7607014 | chr2 | 73730173 | RAB11FIP5 | 26056 | 0.06 | cis | ||
| rs7598660 | chr2 | 73740424 | RAB11FIP5 | 26056 | 0.03 | cis | ||
| rs11688718 | chr2 | 73760938 | RAB11FIP5 | 26056 | 0.18 | cis | ||
| rs13391552 | chr2 | 73818935 | RAB11FIP5 | 26056 | 0.1 | cis | ||
| rs6710438 | chr2 | 73820107 | RAB11FIP5 | 26056 | 0.09 | cis | ||
| rs4852316 | chr2 | 73919657 | RAB11FIP5 | 26056 | 0.1 | cis | ||
| rs12624267 | chr2 | 73986930 | RAB11FIP5 | 26056 | 0.16 | cis | ||
| rs17013209 | chr1 | 208925928 | RAB11FIP5 | 26056 | 0.19 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
死神:胎儿(13 -26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section V. Pathway annotation
| Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
|---|---|---|---|
| KEGG ENDOCYTOSIS | 183 | 132 | All SZGR 2.0 genes in this pathway |
| CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS DN | 142 | 95 | All SZGR 2.0 genes in this pathway |
| CHEBOTAEV GR TARGETS UP | 77 | 62 | All SZGR 2.0 genes in this pathway |
| GRAESSMANN APOPTOSIS BY DOXORUBICIN UP | 1142 | 669 | All SZGR 2.0 genes in this pathway |
| GRAESSMANN RESPONSE TO MC AND DOXORUBICIN UP | 612 | 367 | All SZGR 2.0 genes in this pathway |
| MOREAUX MULTIPLE MYELOMA BY TACI UP | 412 | 249 | All SZGR 2.0 genes in this pathway |
| REN ALVEOLAR RHABDOMYOSARCOMA DN | 408 | 274 | All SZGR 2.0 genes in this pathway |
| BURTON ADIPOGENESIS PEAK AT 0HR | 63 | 48 | All SZGR 2.0 genes in this pathway |
| MASSARWEH TAMOXIFEN RESISTANCE UP | 578 | 341 | All SZGR 2.0 genes in this pathway |
| MOOTHA PGC | 420 | 269 | All SZGR 2.0 genes in this pathway |
| CHEN METABOLIC SYNDROM NETWORK | 1210 | 725 | All SZGR 2.0 genes in this pathway |
| WONG ADULT TISSUE STEM MODULE | 721 | 492 | All SZGR 2.0 genes in this pathway |
| CHYLA CBFA2T3 TARGETS UP | 387 | 225 | All SZGR 2.0 genes in this pathway |
| LINSLEY MIR16 TARGETS | 206 | 127 | All SZGR 2.0 genes in this pathway |
| KRIEG HYPOXIA NOT VIA KDM3A | 770 | 480 | All SZGR 2.0 genes in this pathway |